Leeward Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Buy |
716
+58
| +9% | +$25.8K | 0.1% | 80 |
|
|
2025
Q1 | $319K | Sell |
658
-357
| -35% | -$173K | 0.12% | 68 |
|
|
2024
Q4 | $409K | Sell |
1,015
-997
| -50% | -$401K | 0.15% | 63 |
|
|
2024
Q3 | $936K | Buy |
2,012
+5
| +0.2% | +$2.33K | 0.35% | 57 |
|
|
2024
Q2 | $941K | Sell |
2,007
-6,679
| -77% | -$3.13M | 0.38% | 54 |
|
|
2024
Q1 | $3.63M | Buy |
8,686
+127
| +1% | +$53.1K | 1.54% | 23 |
|
|
2023
Q4 | $3.48M | Sell |
8,559
-343
| -4% | -$140K | 1.68% | 20 |
|
|
2023
Q3 | $3.1M | Buy |
8,902
+1,375
| +18% | +$478K | 1.71% | 17 |
|
|
2023
Q2 | $2.65M | Buy |
+7,527
| New | +$2.65M | 1.52% | 19 |
|